Pregnancy Clinical Trial
Official title:
Determination of Dietary Protein Requirements in Healthy Women During Stages of Lactation
It is well established that a breast-feeding women need more protein in their diet compared to non-lactating women, but how much additional protein is needed remains unclear. There is reason to believe that the current Dietary Reference Intake (DRI) recommendations for breast-feeding women are too low. To gain better understanding, we plan to study healthy breast-feeding women 20 - 45 yrs, between 3 - 5 months lactation and 6 - 8 months lactation. We will use the indicator amino acid oxidation technique (IAAO), which is a modern, quick and safe research method.
Purpose:
To determine the dietary protein intake requirement in healthy lactating women during the
exclusive breast-fed period (3 - 5 months lactation) and during weaning (6 - 8 months
lactation).
Hypothesis:
Recent stable isotope-based research using the IAAO technique indicate that current protein
intake recommendations are underestimated in adults by ~40 %, in school aged children ~75 %
and pregnant women during early and late gestation by ~39 % and ~73 %, respectively.
Therefore we hypothesize that that protein requirements will be increased during both phases
of lactation above that of the current recommendations
Justification:
The WHO advocates that all newborn infants are exclusively breast-fed for the first 6 months
of life, followed by a period of weaning, with appropriate complementary feeds, which is
recommended to continue until the child's second birthday. The period of lactation from the
mother's perspective of up to 2 years for each child, represents a considerable period of
adult life. Adequate protein intake during lactation is important - if a woman's dietary
intake of protein is inadequate, her own lean mass will be depleted to support the growth of
the infant. Currently, dietary protein intake recommendations are based on nitrogen balance
studies conducted in men and recommendations for breast-feeding women are extrapolated from
these studies, and there is little breast-feeding specific data.
Objectives:
To determine the protein requirements during lactation and examine whether protein needs are
significantly altered during exclusive breastfeeding (~3 - 5 mo post parturition) and partial
breast feeding (~6 - 8 mo post parturition).
Research design:
A minimum of 10 women will be recruited. Each mother will participate in up to 8 study days,
4 during the exclusively breast-fed period and 4 during the partial breast-fed period, for a
total of 40 data points (study days) during each lactation period. We hope to retain the same
women for all 8 study days to minimize data variability.
Potential participants will meet us for a preliminary assessment where we will evaluate their
eligibility to participate in the study. The preliminary assessment will take approximately 1
hour during which we will examine body composition (Bioelectrical impedance, skin-fold
measurements, height and weight), resting energy expenditure (by indirect calorimetry) and
medical history (questionnaire). We will collect a 3 day food diary, to determine usual food
intake and food preferences. Based on the 3 day food record we will prescribe a standardized
diet two days prior to the study day to ensure protein intake of 1.5 g/kg/day and 1.7 x
resting energy.
During each study day, the participants will randomly receive 1 of 40 test protein intakes.
Each subject will participate in one study day at approximately 14, 16, 18, 20 weeks
postpartum and 24, 28, 30 and 32 weeks postpartum, respectively, for a total of up to 8 study
days.
The test protein intakes will be administered in an experimental diet. The study day diets
will consist of 8 isocaloric and isonitrogenic meals provided hourly, each meal presenting
1/12 of the daily energy requirement. Study day diet is composed of a crystalline amino acid
mixture based on the composition of egg-protein, flavored with orange Tang, orange Kool-aid
crystals and corn oil.
A stable isotope tracer will be added to the 5th - 8th meal. We will measure the rate of
oxidation of this tracer expired in breath (F13CO2), and flux of this tracer by its
enrichment in urine.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Completed |
NCT02379728 -
Ghana PrenaBelt Trial: A Positional Therapy Device to Reduce Still-Birth
|
N/A | |
Terminated |
NCT02537145 -
PregnanT Moms Measure - Do-It-Yourself Health Monitoring and Simulation of Health in Pregnant Women
|